Report error Found 520 Enz. Inhib. hit(s) with all data for entry = 10493
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:96 Well plates were coated with 111 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS ...More data for this Ligand-Target Pair
